$27.180
+0.802 (+2.95%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
¿Debería comprar acciones de Lycia Therapeutics, Inc. Common Stock?
Lycia Therapeutics, Inc. is currently trading at $27.18, which is 49.6% of its 52-week range. While the stock has shown a strong year-to-date increase of 51%, it has recently declined by 5.79% over the past five days. The lack of a P/E ratio and high price-to-sales ratio of 310.1 indicate potential overvaluation concerns. The main risk is the recent decline in IPO activity, which may affect market sentiment and investor confidence.
LYCA cerró en $27.18 el Monday, tras subir +2.95%
Lycia Therapeutics, Inc. Common Stock (LYCA) last closed at $27.1800003, gaining +2.95%. These facts feed the 1-day and 1-week LYCA price prediction above.
Factores de la previsión
Los factores de la previsión de Lycia Therapeutics, Inc. Common Stock (LYCA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Seasonality
Bullish
Análisis de estacionalidad de LYCA
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.